List of Groups
This is a world-wide list of patient groups supporting those patients and families affected with Chronic Myeloid Leukemia (CML). If your group not listed here, please register. If details have changed, please contact us.
Or click on the map to have an interactive, fast glance:
Organisations
- Middle East and Africa
- Latin America
- Argentina: ALMA - Asociación Leucemia Mieloide Argentina
- Brasil: Associação Brasileira de Linfoma e Leucemia, "ABRALE"
- Colombia: Fundación Esperanza Viva (Hope Alive Foundation)
- Costa Rica: AGALEMO (Asociación Amalia y Glenn Dewey para Pacientes de Leucemia, Mieloma y otros)
- Dominican Republic: Un Paso Max
- Ecuador: Ecuatorian Association to support patients with cancer, hope and life
- Guatemala: ASOPALEU - Asociación de Pacientes con Leucemia Mieloide Crónica
- Peru: ESPERANTRA
- Venezuela: Asociacion de Ayuda a Pacientes Hemato-Oncologicos "ASAPHE"
- North America
- Asia-Pacific
- Australia: Leukaemia Foundation
- China: New Sunshine Charity Foundation
- China: Shanghai Roots & Shoots: CML Home of Hope
- Hong Kong: Adult Blood Cancer Group
- India: Friends of Max
- Japan: IZUMI (The Association of CML patients & families)
- Kazakhstan: Association of patients with hemoblastoses
- Malaysia: Max Family
- New Zealand: Leukaemia & Blood Foundation
- Philippines: Touched By Max
- South Korea: Korea Blood Cancer Association
- Thailand: MaxSmiles
- Thailand: Thai CML Patients Group
- Europe
- Azerbaijan: 'Birlikde' Leukemia Patients Support Organisation
- Azerbaijan: Charter Of "Fighting Leukemia" Public Union
- Bosnia and Herzegovina: ZAGRLJAJ Association of leukemia and lymphoma patients "Embrace" (Udruga oboljelih od leukemije i limfoma)
- Bulgaria: Association of People Suffering from Chronic Myeloid Leukemia
- Croatia: Croatian Leukemia and Lymphoma Society (HULL Hrvatska udruga leukemija i limfomi)
- Czech Republic: Diagnoza CML
- Denmark: LYLE, Association for lymphatic cancer and leukemia
- Estonia: Eesti Leukeemia ja Lümfoomihaigete Liit (Estonian Leukaemia and Lymphoma Patients Society)
- Finland: The Finnish CML Patient Network
- France: Leucemie espoir 06
- France: LMC France
- France: Vivre avec la LMC
- Germany: German Leukemia and Lymhoma Aid (DLH, Deutsche Leukämie- und Lymphom-Hilfe e.V.)
- Germany: Leukämie-Online / LeukaNET
- Germany: Parents' Organisation for Children with CML (Elternverein für Kinder mit CML e.V.)
- Hungary: CML & GIST Beteg Egyesület
- Ireland: CML Society
- Italy: AIP - Italian Patients' Association of CML
- Italy: Gruppo AIL Pazienti Leucemia Mieloide Cronica
- Kosovo Association for Supporting Chronic Leukemia Patients
- Latvia: Association of Support for Leukemia Patients (Leikemijas slimnieku atbalsta biedriba)
- Lithuania: Community of Oncohematological Patients (COHP) KRAUJAS
- Macedonia: Association for help in treatment of patients with CML
- Netherlands: SCL Stichting Contactgroep Leukemie
- Poland: The Association for Blood Cancer Patients Aid (Stowarzyszenie Pomocy Chorym na Nowotwory Krwi)
- Poland: The Nationwide Association for CML Patients Aid
- Portugal: Associação Portuguesa contra a Leucemia
- Portugal: Portuguese Leukemia and Lymphoma Association
- Romania: "Fighting and Preventing Lymphoma and Leukemia" Leukemia Association
- Russia: CML-Stop
- Russia: Sodeystvie (Assistance)
- Serbia: CML Association of Serbia
- Slovakia: CML Life
- Slovenian Lymphoma and Leukemia Patient Association, L&L
- Spain: AEAL, Asociación Española de Afectados por Linfoma, Mieloma y Leucemia
- Sweden: Blodcancerförbundet
- Switzerland: Foundation for Advancement of Bone Marrow Transplantation
- Turkey: The Leukemia, Lymphoma, Myeloma Patients Research and Education Society (LLMBIR)
- UK: CML UK - Facebook Group
- UK: CMLSupport
- UK: Leukaemia CARE
- Ukraine: OSANNA
Powered By http://tuts4you.de/
-
Generics
-
Scientific Literature on Generics and Copies
-
Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: a randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers (Clin Ther. 2009)
-
Failure of a non-authorized copy product to maintain response achieved with imatinib in a patient with chronic phase chronic myeloid leukemia: a case report.
-
Failure of copy Imatib (CIPLA, India) to maintain hematologic and cytogenetic responses in chronic myeloid leukemia in chronic phase (Int J Hematol. 2010
-
